BC Platforms to provide genomics data management solution to Codigo46 powered by the Microsoft Azure cloud

November 28, 2016

BC Platforms, a world leader in genomic data management solutions, today announced that it will collaborate with Microsoft to provide integrated genomic data management solutions in the cloud to Codigo46. Codigo46, an emerging Mexican company, is building and managing the largest biobank in Latin-America in co-operation with Mexican health and research authorities. Codigo46 will genotype one million Mexican subjects in the next three years for the purpose of delivering personalized medicine benefits to patients. BC Platforms signed a partnership with Codigo46 in July 2016.

Tero Silvola, CEO of BC Platforms, said: “Since the announcement earlier this year of our collaboration with Microsoft, we have been optimizing our product offerings for Azure utilizing both advancements in software and cloud hardware. Microsoft has built a scalable cloud-based service that enables us to easily and reliably process large volumes of genomic data and we are leveraging this in our partnership with Codigo46.”

Lorenza Haddad, Chief Executive Officer at Codigo46, commented: “I am very excited about our partnership with BC Platforms which now includes the addition of Microsoft. We believe that these collaborations will allow us to reach our goals of advancing research in Latin America and in the global field of personalized medicine. Our vision is for each patient to have a bespoke pharmacogenomics profile enabling them to receive the ideal personalized treatment. Initially we will focus on understanding metabolic diseases, such as diabetes, and its complications, as one of the most significant unmet needs in Mexico. We believe that with the support of both Microsoft and BC Platforms we can achieve our ambitious goals and change the face of healthcare and wellbeing in Latin America and beyond.”

David Heckerman, distinguished scientist and director of the Microsoft Genomics team, commented: “Microsoft is committed to being a leader in genomics solutions through our Microsoft Azure platform. In collaboration with BC Platforms and Codigo46, we are supporting the advancement of academic and commercial research with the goal of improving health outcomes for individuals, communities, and large populations.”

For more information about Microsoft Genomics and empowering precision medicine through genomics sequencing, see http://www.microsoft.com/genomics.

About BC Platforms
BC Platforms is a world leader in providing powerful genomic data management solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies. Our high performing genomic data management platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information. BC Platforms’ vision is to revolutionize decision making in drug development to bring clinical benefits to patients. Founded in 1997, the Company has a strong scientific heritage underpinned by 18 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors.

We currently provide solutions to over 50 leading international institutions in 18 countries including top-tier academic and hospital research groups, major pharmaceutical and agricultural companies. Our management team consists of industry leaders with over 100 years of combined experience in life sciences, computational biology and industrial technology. BC Platforms has global operations with its headquarters in Basel, Switzerland, research and development located in Helsinki, Finland, and sales and marketing based in London, Boston, and Vancouver.

About Codigo46
Codigo46 is an emerging Mexican company partnering with world leaders in the genomic field to build the most extensive biobank in Latin America. Codigo46 wants to bridge the gap between the promises of personalized medicine and reality, contributing to research, development, and health programs. Using Illumina’s recently announced Infinium® Global Screening Array (GSA), for genetic risk screening of large global populations, and BC Platforms data management solutions, we will revolutionize the genomics field in Latin America, population risk assessment, and healthcare.

Codigo46 is located in Cuernavaca, Mexico, strategically located in the city where the best and brightest genomic scientists of Mexico are trained: the Genomic Sciences Center from UNAM. Our team consists of passionate, visionary, and knowledgeable people in bioinformatics, genetics, and international business. We believe in the ability of genomics to build a better future through the contribution and leadership in the generation of knowledge concerning diseases, wellness, populations, and ourselves.